Rifamycin sodium

Overview

Rifamycin sodium (Rifamycin SV monosodium) is an orally active ansamycin antibiotic . Rifamycin sodium inhibits DNA-dependent RNA synthesis . Rifamycin sodium has antibacterial activity against Mycobacterium tuberculosis . Rifamycin sodium interferes with hepatic bile acid metabolism. Rifamycin sodium has anti-inflammatory effects. Rifamycin sodium can be used in the study of Mycobacterium tuberculosis , Bacteroides fragilis infection , and Lipopolysaccharide ( HY-D1056B3 )-induced inflammation.

Application

Products | Products > Disease Areas > Mycobacterium Tuberculosis Infection | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Bacterial Infection | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > DNA/RNA Synthesis

Product Information

• Catalog No.: HY-B1907
• CAS No.: 14897-39-3
• Molecular Formula: C37H46NNaO12
• Molecular Weight: 719.75
• Purity: 99.56%
• Storage: -20°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.08 mg/mL (2.89 mM); Clear solution
• Availability: In-stock

Source

Original product source